H19 and plasma cell myeloma: Plasma H19 serves as a diagnostic biomarker for gastric cancer [56], while serum LINC00161 or taurine up-regulated 1 (TUG1) levels contribute to assessing the tumor stage and progression of hepatocellular carcinoma [57] and multiple myeloma [58], respectively.